HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NMDA receptor gene variations as modifiers in Huntington disease: a replication study.

Abstract
Several candidate modifier genes which, in addition to the pathogenic CAG repeat expansion, influence the age at onset (AO) in Huntington disease (HD) have already been described. The aim of this study was to replicate association of variations in the N-methyl D-aspartate receptor subtype genes GRIN2A and GRIN2B in the "REGISTRY" cohort from the European Huntington Disease Network (EHDN). The analyses did replicate the association reported between the GRIN2A rs2650427 variation and AO in the entire cohort. Yet, when subjects were stratified by AO subtypes, we found nominally significant evidence for an association of the GRIN2A rs1969060 variation and the GRIN2B rs1806201 variation. These findings further implicate the N-methyl D-aspartate receptor subtype genes as loci containing variation associated with AO in HD.
AuthorsCarsten Saft, Jörg T Epplen, Stefan Wieczorek, G Bernhard Landwehrmeyer, Raymund A C Roos, Justo Garcia de Yebenes, Matthias Dose, Sarah J Tabrizi, David Craufurd, REGISTRY Investigators of the European Huntington's Disease Network, Larissa Arning
JournalPLoS currents (PLoS Curr) Vol. 3 Pg. RRN1247 (Oct 04 2011) ISSN: 2157-3999 [Electronic] United States
PMID21989477 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: